-
2023-505423-31-00
5
2024-08-08
advanced or metastatic gastric adenocarcinoma, gastroesophageal juncti
-
2023-507204-31-00
5
2024-07-26
Hidradenitis Suppurativa
-
2023-505722-33-00
4
2024-04-15
cholangiocarcinoma or gallbladder carcinoma
-
2022-502161-19-00
5
2024-03-12
Chronic Spontaneous Urticaria
-
2023-503355-98-00
7
2024-01-24
Prion diseases
-
2022-502010-85-00
9
2023-12-20
Non-Squamous Non-Small Cell Lung Cancer
-
2022-501863-41-00
5
2023-11-13
Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small
-
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
-
2023-503652-27-00
5
2023-10-06
Melanoma
-
2023-505054-17-00
6
2023-09-15
metastatic TTF-1 negative lung adenocarcinoma
-
2022-502322-41-00
5
2023-09-12
Metastatic breast cancer
-
2024-512980-29-00
4
2023-08-28
T1-T2N0 esophageal adenocarcinoma including gastroesophageal
junction
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501576-25-00
5
2023-07-07
Melanoma
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2024-510742-13-00
5
2023-04-19
Pediatric low-grade glioma harboring an activating RAF alteration requ
-
2024-517580-23-00
1
2023-03-07
Sarcoma
-
2024-512785-33-00
10
2023-03-01
Active Idiopathic Inflammatory Myopathy (IIM)
-
2024-511594-30-00
5
2023-02-23
Relapsed/Refractory Follicular Lymphoma
-
2024-510818-33-00
5
2023-01-24
Chronic Spontaneous Urticaria
-
2023-508701-24-00
5
2022-11-21
Locoregional Hepatocellular Carcinoma (HCC)
-
2023-505772-30-00
5
2022-11-09
Melanoma
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma